Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6<br />
<strong>Solvay</strong> Global Annual Report 2005<br />
The Board of Directors<br />
The Board of Directors is the<br />
highest management body of the<br />
company. The law grants it all<br />
powers not given, by law or by<br />
the by-laws, to the Shareholders’<br />
Meeting.<br />
In the case of <strong>Solvay</strong> S.A., the<br />
Board of Directors has reserved<br />
certain key areas for itself and<br />
has delegated the remainder of its<br />
powers to an Executive Committee.<br />
Key senior appointments<br />
in 2006<br />
On May 3, 2005, in accordance<br />
with the Corporate Governance<br />
rules to which it is committed,<br />
and with the full agreement of<br />
the persons involved, the Board<br />
of Directors announced a series<br />
of key appointments, at the head<br />
of <strong>Solvay</strong> S.A. decided on<br />
unanimously.<br />
The Group’s two highest management<br />
bodies, the Board of<br />
Directors and the Executive<br />
Committee, will see major changes<br />
in 2006. Each will have a change<br />
of Chairman and other new<br />
appointments.<br />
Chairman of<br />
the Board of Directors<br />
of <strong>Solvay</strong> S.A.<br />
Baron Daniel Janssen, who has<br />
reached the age limit of 70, will<br />
step down as Chairman of the<br />
Board of Directors of <strong>Solvay</strong> S.A.<br />
on May 9, 2006 at the end of the<br />
General Shareholders’ Meeting,<br />
after 22 years on the Board, the<br />
last 8 of them as its Chairman.<br />
Baron Janssen also spent 14 years<br />
on the Executive Committee,<br />
12 of them as Chairman.<br />
Aloïs Michielsen, currently<br />
Chairman of the Executive<br />
Committee, will succeed him as<br />
Chairman of the Board of Directors.<br />
In this position, Mr. Michielsen,<br />
now 64 years old, will continue<br />
his active career at <strong>Solvay</strong>, which<br />
already spans 37 years. He has<br />
spent 16 years on the Executive<br />
Committee, including 4 as Vice-<br />
Chairman and 8 as Chairman.<br />
Effective the same date,<br />
Denis <strong>Solvay</strong> will become Vice-<br />
Chairman of the Board of Directors.<br />
Chairman of<br />
the Executive Committee<br />
of <strong>Solvay</strong> S.A.<br />
Mr. Michielsen will leave the<br />
Executive Committee, and his<br />
position as its Chairman, on<br />
May 9, 2006.<br />
Effective May 9, 2006 the Chairman<br />
of the Executive Committee<br />
will be Christian Jourquin.<br />
Mr. Jourquin (58) has spent his<br />
entire 35-year career in the Group,<br />
including 10 years on the Executive<br />
Committee.<br />
He joined the Board of Directors<br />
on June 2, 2005.<br />
Mr. Jourquin, a graduate of the<br />
<strong>Solvay</strong> business school of the<br />
Free University of Brussels, was<br />
General Manager of the Chemicals<br />
<strong>Sector</strong> for the past 6 years until<br />
April 30, 2006.<br />
Before that, he successfully<br />
managed other major Group<br />
entities, including <strong>Solvay</strong> Duphar<br />
in the Netherlands between 1980<br />
and 1990, which at the time represented<br />
a large part of the Group’s<br />
international pharmaceutical<br />
activities, the Iberian peninsula<br />
between 1990 and 1996, <strong>Solvay</strong><br />
Interox in 1996 and the Processing<br />
<strong>Sector</strong> from 1997 to 2000.<br />
General Manager<br />
of North American<br />
René Degrève (63), an outstanding<br />
General Manager of Finance and<br />
a member of the Executive<br />
Committee for the past 15 years,<br />
has been appointed General<br />
Manager for North America, replacing<br />
David Birney, who retired on<br />
March 31, 2006.<br />
He will cease being a Director,<br />
a post which he has held for<br />
8 years.<br />
Mr. Degrève will remain a member<br />
of the Executive Committee.<br />
General Manager<br />
of Finance<br />
Bernard de Laguiche (46) has been<br />
appointed General Manager of<br />
Finance, effective March 1, 2006,<br />
to replace Mr. Degrève.<br />
Mr. Laguiche remains a member<br />
of the Executive Committee, which<br />
he joined in 1998.<br />
He was appointed a Director at the<br />
Ordinary Shareholders’ Meeting of<br />
June 2, 2005, effective March 1,<br />
2006, to replace Mr. Degrève.<br />
Mr. de Laguiche has a commercial<br />
engineering degree from the<br />
University of St Gallen (Switzerland).<br />
He joined <strong>Solvay</strong> in 1987 and<br />
has held a number of positions of<br />
responsibility in Belgium, Germany<br />
and the United Kingdom. Until the<br />
end of 2005 he was Managing<br />
Director of <strong>Solvay</strong> Solexis in Milan.<br />
General Manager<br />
of the Chemicals <strong>Sector</strong><br />
Vincent De Cuyper (45) will<br />
become General Manager of the<br />
Chemicals <strong>Sector</strong> and a member<br />
of the Executive Committee<br />
from May 1, 2006, replacing<br />
Christian Jourquin, who has been<br />
appointed Chairman of the<br />
Executive Committee.<br />
Mr. De Cuyper is a chemical engineer<br />
from the University of Louvain.<br />
He has spent his entire career at<br />
<strong>Solvay</strong>, where he was previously<br />
Managing Director General of<br />
Vinythai, a listed Thai company.<br />
The attached table shows the composition<br />
of the Board of Directors<br />
as of January 1, 2006, together<br />
with the changes approved in 2005<br />
to take effect during the course<br />
of 2006.